Bitterman Roni, Raz-Pasteur Ayelet, Azzam Zaher S, Karban Amir, Levy Yishai, Hayek Tony, Braun Eyal, Oren Ilana, Bar-Lavi Yaron, Kassis Imad, Hussein Khetam, Paul Mical
Internal Medicine B, Rambam Health Care Campus, Haifa.
Internal Medicine A, Rambam Health Care Campus, Haifa.
Harefuah. 2017 Sep;156(9):573-577.
Antibiotic stewardship programs (ASP) are designed to optimize antibiotic use in hospitals. Antibiotic consumption is one of the measures assessing the effects of ASPs.
To evaluate the effect of an ASP on antibiotic consumption in our hospital and compare it to hospitals in Israel and worldwide.
Between October 2012 and March 2013 an ASP was implemented in Rambam Hospital. The program included educational activities, publication of local guidelines for empirical antibiotic treatment, structured infectious diseases consultations, pre-authorization antibiotic restrictions and stop orders. We compared antibacterial antibiotic consumption in defined daily doses (DDD)/100 hospital days (HD) between the periods before (1/2010-3/2013) and after (4/2013-9/2014) implementing the ASP. The study was conducted in the medical departments, hematology, the intensive care unit (ICU) and all pediatric wards.
Total antibiotic consumption before implementing the ASP was 96±11.2 DDD/100 HD in medical departments, 186.4±42.8 in the ICU and 185.5±59 in hematology; all values were higher than the worldwide-reported averages for these departments. Following the ASP, total antibiotic consumption decreased by 12% (p=0.008) in the medical departments and by 26% (p=0.002) in hematology, mostly due to reductions in non-restricted antibiotics. No significant changes were observed overall in the ICU and in pediatric wards. There was a significant reduction in consumption of vancomycin and carbapenems in all settings, the latter was reduced to nearly half. Amikacin use quadrupled in the medical departments.
Implementation of an ASP lead to a reduction in non-restricted and restricted antibiotic consumption, especially carbapenems.
抗生素管理计划(ASP)旨在优化医院内抗生素的使用。抗生素消耗量是评估ASP效果的指标之一。
评估我院ASP对抗生素消耗量的影响,并与以色列及全球其他医院进行比较。
2012年10月至2013年3月期间,拉姆巴姆医院实施了ASP。该计划包括教育活动、发布经验性抗生素治疗的本地指南、结构化传染病会诊、预授权抗生素限制和停药指令。我们比较了实施ASP前后(2010年1月 - 2013年3月与2013年4月 - 2014年9月)各科室按限定日剂量(DDD)/100住院日(HD)计算的抗菌药物消耗量。研究在内科、血液科、重症监护病房(ICU)及所有儿科病房开展。
实施ASP前,内科抗生素总消耗量为96±11.2 DDD/100 HD,ICU为186.4±42.8,血液科为185.5±59;所有这些数值均高于全球报道的这些科室的平均水平。实施ASP后,内科抗生素总消耗量下降了12%(p = 0.008),血液科下降了26%(p = 0.002),主要是由于非限制使用抗生素的减少。ICU和儿科病房总体未观察到显著变化。所有科室万古霉素和碳青霉烯类药物的消耗量均显著下降,后者降至近一半。内科阿米卡星的使用量增加了四倍。
实施ASP导致非限制和限制使用的抗生素消耗量减少,尤其是碳青霉烯类药物。